| Sku |
AAP31137 |
| Old sku |
AAPP01876 |
| Price |
$99.00 |
| Name |
RXRB Peptide (AAP31137) |
| Purchase info |
To purchase this peptide:
- Copy peptide sku
- Click on this link
- Paste into field "Peptide Sku"
|
| Size |
100 ug |
| Gene |
RXRB |
| Alias symbols |
DAUDI6, H-2RIIBP, MGC1831, NR2B2, RCoR-1 |
| Gene id |
6257 |
| Description of target |
RXRB is a member of the retinoid X receptor (RXR) family of nuclear receptors which are involved in mediating the effects of retinoic acid (RA). This receptor forms homodimers with the retinoic acid, thyroid hormone, and vitamin D receptors, increasing both DNA binding and transcriptional function on their respective response elements. This gene encodes a member of the retinoid X receptor (RXR) family of nuclear receptors which are involved in mediating the effects of retinoic acid (RA). This receptor forms homodimers with the retinoic acid, thyroid hormone, and vitamin D receptors, increasing both DNA binding and transcriptional function on their respective response elements. The gene lies within the major histocompatibility complex (MHC) class II region on chromosome 6. An alternatively spliced transcript variant has been described, but its full length sequence has not been determined. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Entrez Gene record to access additional publications.This gene encodes a member of the retinoid X receptor (RXR) family of nuclear receptors which are involved in mediating the effects of retinoic acid (RA). This receptor forms homodimers with the retinoic acid, thyroid hormone, and vitamin D receptors, increasing both DNA binding and transcriptional function on their respective response elements. The gene lies within the major histocompatibility complex (MHC) class II region on chromosome 6. An alternatively spliced transcript variant has been described, but its full length sequence has not been determined. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Entrez Gene record to access additional publications. |
| Swissprot id |
P28702 |
| Protein accession num |
NP_068811 |
| Nucleotide accession num |
NM_021976 |
| Protein size |
533 amino acids |
| Molecular weight |
57kDa |
| Application |
WB |
| Partner proteins |
NCOA3,THRB,AKAP13,MAP4,NCOA1,NCOA3,NR0B2,NR1H2,NR1H3,NR1I2,NR2C2,NR2E3,NR4A2,NRIP1,PPARD,PPARG,RARA,RARB,RARG,RXRB,SPOP,TACC2,TAF11,THRA,THRB,VDR,AKAP13,NR1H2,NRIP1,RARA,SPOP |
| Quality control |
The peptide is characterized by mass spectroscopy |
| Key reference |
Chang,S.C., (er) Carcinogenesis (2008) In press |
| Description |
This is a synthetic peptide designed for use in combination with anti-RXRB antibody (Catalog #: P100796_P050) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details. |
| Product format |
Lyophilized powder |
| Reconstitution and storage |
Add 100ul of sterile PBS. Final peptide concentration is 1 mg/ml in PBS. For longer periods of storage, store at -20C. Avoid repeat freeze-thaw cycles. |
| Lead time |
Domestic: within 24 hours delivery International: 3-5 business days |
| Protocol |
|
| Tips |
See our General FAQ page. |
| Availability |
In Stock |
